(Q45013677)

8 December 2017

Signalling pathways involved in multisite phosphorylation of the transcription factor ATF-2. (English)

1 reference

8 December 2017

0 references

2

Roger J Davis

1 reference

8 December 2017

Simon Morton

1

1 reference

PubMed ID

15304344

8 December 2017

Philip Cohen

series ordinal

3

1 reference

PubMed ID

15304344

8 December 2017

language of work or name

English

0 references

publication date

1 August 2004

1 reference

8 December 2017

1 reference

8 December 2017

572

1 reference

8 December 2017

177-183

1 reference

8 December 2017

1-3

1 reference

Transcription factor ATF cDNA clones: an extensive family of leucine zipper proteins able to selectively form DNA-binding heterodimers

8 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

Cross-family dimerization of transcription factors Fos/Jun and ATF/CREB alters DNA binding specificity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

Retinoblastoma gene product activates expression of the human TGF-β2 gene through transcription factor ATF-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

A specific member of the ATF transcription factor family can mediate transcription activation by the adenovirus E1a protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

Promoter targeting by adenovirus E1a through interaction with different cellular DNA-binding domains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

Transcription factor ATF2 regulation by the JNK signal transduction pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

c-Jun NH(2)-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

Growth factors can activate ATF2 via a two-step mechanism: phosphorylation of Thr71 through the Ras-MEK-ERK pathway and of Thr69 through RalGDS-Src-p38

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

Pro-inflammatory cytokines and environmental stress cause p38 mitogen-activated protein kinase activation by dual phosphorylation on tyrosine and threonine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

Blockade of the MAP kinase pathway suppresses growth of colon tumors in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

The specificities of protein kinase inhibitors: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

Identification of a novel inhibitor of mitogen-activated protein kinase kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2004.07.031

10.1016/J.FEBSLET.2004.07.031

21 January 2018

Identifiers

DOI

1 reference

8 December 2017

1 reference

PubMed ID

15304344